Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets-Reference-Cited by-同舟云学术

Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets

Published:2023-09-28 Issue:10 Volume:13 Page:1446
ISSN:2075-4426
Container-title:Journal of Personalized Medicine
language:en
Short-container-title:JPM

Author:

Gredic Marija¹^ORCID,Hadzic Stefan¹^ORCID

Affiliation:

1. Excellence Cluster Cardiopulmonary Institute (CPI), University of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig University, 35392 Giessen, Germany

Abstract

Pulmonary hypertension (PH) is a progressive and life-threatening disease characterized by increased pulmonary arterial pressure, which leads to right heart hypertrophy and eventually right heart failure [...]

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Link

https://www.mdpi.com/2075-4426/13/10/1446/pdf

Reference22 articles.

1. Pulmonary hypertension in chronic obstructive pulmonary disease;Gredic;Br. J. Pharmacol.,2020

2. Riociguat for treatment of pulmonary hypertension in COPD: A translational study;Pichl;Eur. Respir. J.,2019

3. Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets-From Bench to Bed Site;Gajecki;Oxidative Med. Cell. Longev.,2020

4. Mechanisms of disease: Pulmonary arterial hypertension;Schermuly;Nat. Rev. Cardiol.,2011

5. Martin de Miguel, I., Cruz-Utrilla, A., Oliver, E., and Escribano-Subias, P. (2023). Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension. Int. J. Mol. Sci., 24.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the genetic landscape of pulmonary arterial hypertension in Indian patients: A transcriptome study;Respiratory Medicine;2024-09

2. Mendelian randomization study on causal association of TEF and circadian rhythm with pulmonary arterial hypertension;Respiratory Research;2024-08-07